Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?
D000818:Animals; D001060:Aporphines / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D002090:Butyrophenones / Q000494:pharmacology; D002375:Catalepsy; D004149:Dioxoles / Q000494:pharmacology; D005116:Extrapyramidal Tracts / Q000187:drug effects*; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects*; D008297:Male; D008787:Metoclopramide / Q000494:pharmacology; D010546:Perphenazine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D013141:Spiro Compounds / Q000494:pharmacology; D013881:Thioridazine / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*
D001060:Aporphines; D001565:Benzoates; D002090:Butyrophenones; D004149:Dioxoles; D010880:Piperidines; D013141:Spiro Compounds; D014149:Tranquilizing Agents; D010546:Perphenazine; D008787:Metoclopramide; D013881:Thioridazine